Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients

Karen Nuytemans, Rosa Rademakers, Jessie Theuns, Philippe Pals, Sebastiaan Engelborghs, Barbara Pickut, Tim de Pooter, Karin Peeters, Maria Mattheijssens, Marleen Van den Broeck, Patrick Cras, Peter Paul De Deyn, Christine van Broeckhoven

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

We determined the prevalence of mutations in two major functional domains of the leucine-rich repeat kinase 2 gene (LRRK2) in Belgian Parkinson's disease (PD) patients (N=304) of which 18.1% were familial PD patients. Ten patients were heterozygous for five different missense mutations (3.29%) of whom six carried the same mutation p.R1441C (1.97%). All six p.R1441C carriers were familial PD patients explaining 10.7% of familial PD in the Belgian patient group. Moreover, they shared a common disease haplotype of 21 consecutive markers in a region of 438kb, suggesting that they are distant descendants of a single common ancestor. Clinically, p.R1441C carriers had typical levodopa-responsive parkinsonism with tremor as the most common presenting feature. Their age at onset was highly variable and ranged from 39 to 73 years, suggesting the influence of modifying factors. The remaining four patients were heterozygous each for a novel missense mutation located in the Roc or kinase domain. The pathogenic nature of these mutations remains to be determined, though we have genetic evidence that at least some represent rare but benign variants rather than causal mutations. The latter observation indicates that prudence is needed in diagnostic testing of LRRK2 in PD patients. Functional data should underlie a conclusion on the pathogenic nature of some mutations that have not been conclusively linked to disease.

Original languageEnglish (US)
Pages (from-to)471-479
Number of pages9
JournalEuropean Journal of Human Genetics
Volume16
Issue number4
DOIs
StatePublished - Apr 1 2008
Externally publishedYes

Fingerprint

Leucine
Parkinson Disease
Phosphotransferases
Mutation
Genes
Missense Mutation
Parkinsonian Disorders
Levodopa
Tremor
Age of Onset
Haplotypes
Observation

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients. / Nuytemans, Karen; Rademakers, Rosa; Theuns, Jessie; Pals, Philippe; Engelborghs, Sebastiaan; Pickut, Barbara; de Pooter, Tim; Peeters, Karin; Mattheijssens, Maria; Van den Broeck, Marleen; Cras, Patrick; De Deyn, Peter Paul; van Broeckhoven, Christine.

In: European Journal of Human Genetics, Vol. 16, No. 4, 01.04.2008, p. 471-479.

Research output: Contribution to journalArticle

Nuytemans, K, Rademakers, R, Theuns, J, Pals, P, Engelborghs, S, Pickut, B, de Pooter, T, Peeters, K, Mattheijssens, M, Van den Broeck, M, Cras, P, De Deyn, PP & van Broeckhoven, C 2008, 'Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients', European Journal of Human Genetics, vol. 16, no. 4, pp. 471-479. https://doi.org/10.1038/sj.ejhg.5201986
Nuytemans, Karen ; Rademakers, Rosa ; Theuns, Jessie ; Pals, Philippe ; Engelborghs, Sebastiaan ; Pickut, Barbara ; de Pooter, Tim ; Peeters, Karin ; Mattheijssens, Maria ; Van den Broeck, Marleen ; Cras, Patrick ; De Deyn, Peter Paul ; van Broeckhoven, Christine. / Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients. In: European Journal of Human Genetics. 2008 ; Vol. 16, No. 4. pp. 471-479.
@article{d3e7cf56e5674ebeb2bb474c0321b9fd,
title = "Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients",
abstract = "We determined the prevalence of mutations in two major functional domains of the leucine-rich repeat kinase 2 gene (LRRK2) in Belgian Parkinson's disease (PD) patients (N=304) of which 18.1{\%} were familial PD patients. Ten patients were heterozygous for five different missense mutations (3.29{\%}) of whom six carried the same mutation p.R1441C (1.97{\%}). All six p.R1441C carriers were familial PD patients explaining 10.7{\%} of familial PD in the Belgian patient group. Moreover, they shared a common disease haplotype of 21 consecutive markers in a region of 438kb, suggesting that they are distant descendants of a single common ancestor. Clinically, p.R1441C carriers had typical levodopa-responsive parkinsonism with tremor as the most common presenting feature. Their age at onset was highly variable and ranged from 39 to 73 years, suggesting the influence of modifying factors. The remaining four patients were heterozygous each for a novel missense mutation located in the Roc or kinase domain. The pathogenic nature of these mutations remains to be determined, though we have genetic evidence that at least some represent rare but benign variants rather than causal mutations. The latter observation indicates that prudence is needed in diagnostic testing of LRRK2 in PD patients. Functional data should underlie a conclusion on the pathogenic nature of some mutations that have not been conclusively linked to disease.",
author = "Karen Nuytemans and Rosa Rademakers and Jessie Theuns and Philippe Pals and Sebastiaan Engelborghs and Barbara Pickut and {de Pooter}, Tim and Karin Peeters and Maria Mattheijssens and {Van den Broeck}, Marleen and Patrick Cras and {De Deyn}, {Peter Paul} and {van Broeckhoven}, Christine",
year = "2008",
month = "4",
day = "1",
doi = "10.1038/sj.ejhg.5201986",
language = "English (US)",
volume = "16",
pages = "471--479",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients

AU - Nuytemans, Karen

AU - Rademakers, Rosa

AU - Theuns, Jessie

AU - Pals, Philippe

AU - Engelborghs, Sebastiaan

AU - Pickut, Barbara

AU - de Pooter, Tim

AU - Peeters, Karin

AU - Mattheijssens, Maria

AU - Van den Broeck, Marleen

AU - Cras, Patrick

AU - De Deyn, Peter Paul

AU - van Broeckhoven, Christine

PY - 2008/4/1

Y1 - 2008/4/1

N2 - We determined the prevalence of mutations in two major functional domains of the leucine-rich repeat kinase 2 gene (LRRK2) in Belgian Parkinson's disease (PD) patients (N=304) of which 18.1% were familial PD patients. Ten patients were heterozygous for five different missense mutations (3.29%) of whom six carried the same mutation p.R1441C (1.97%). All six p.R1441C carriers were familial PD patients explaining 10.7% of familial PD in the Belgian patient group. Moreover, they shared a common disease haplotype of 21 consecutive markers in a region of 438kb, suggesting that they are distant descendants of a single common ancestor. Clinically, p.R1441C carriers had typical levodopa-responsive parkinsonism with tremor as the most common presenting feature. Their age at onset was highly variable and ranged from 39 to 73 years, suggesting the influence of modifying factors. The remaining four patients were heterozygous each for a novel missense mutation located in the Roc or kinase domain. The pathogenic nature of these mutations remains to be determined, though we have genetic evidence that at least some represent rare but benign variants rather than causal mutations. The latter observation indicates that prudence is needed in diagnostic testing of LRRK2 in PD patients. Functional data should underlie a conclusion on the pathogenic nature of some mutations that have not been conclusively linked to disease.

AB - We determined the prevalence of mutations in two major functional domains of the leucine-rich repeat kinase 2 gene (LRRK2) in Belgian Parkinson's disease (PD) patients (N=304) of which 18.1% were familial PD patients. Ten patients were heterozygous for five different missense mutations (3.29%) of whom six carried the same mutation p.R1441C (1.97%). All six p.R1441C carriers were familial PD patients explaining 10.7% of familial PD in the Belgian patient group. Moreover, they shared a common disease haplotype of 21 consecutive markers in a region of 438kb, suggesting that they are distant descendants of a single common ancestor. Clinically, p.R1441C carriers had typical levodopa-responsive parkinsonism with tremor as the most common presenting feature. Their age at onset was highly variable and ranged from 39 to 73 years, suggesting the influence of modifying factors. The remaining four patients were heterozygous each for a novel missense mutation located in the Roc or kinase domain. The pathogenic nature of these mutations remains to be determined, though we have genetic evidence that at least some represent rare but benign variants rather than causal mutations. The latter observation indicates that prudence is needed in diagnostic testing of LRRK2 in PD patients. Functional data should underlie a conclusion on the pathogenic nature of some mutations that have not been conclusively linked to disease.

UR - http://www.scopus.com/inward/record.url?scp=41049086705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41049086705&partnerID=8YFLogxK

U2 - 10.1038/sj.ejhg.5201986

DO - 10.1038/sj.ejhg.5201986

M3 - Article

C2 - 18197194

AN - SCOPUS:41049086705

VL - 16

SP - 471

EP - 479

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 4

ER -